Showing results (11-20 of 61) with videos related to
Sort By:
Pageof 7
Neuropsychobiology|November 1, 2014
Bcl1 polymorphism of the glucocorticoid receptor gene and treatment response to milnacipran and fluvoxamine in Japanese patients with depressionHitoshi Takahashi, Keizo Yoshida, Hisashi Higuchi, et al.The Journal of Neuropsychiatry and Clinical Neurosciences|August 21, 2003
Effectiveness of switching to quetiapine for neuroleptic-induced amenorrheaHitoshi Takahashi, Hisashi Higuchi, Mitsuhiro Kamata, et al.Psychiatry and Clinical Neurosciences|April 17, 2008
No predictors of antidepressant patient response to milnacipran were obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale in Japanese patients with major depressive disordersHisashi Higuchi, Kazuhiro Sato, Keizo Yoshida, et al.Psychiatry and Clinical Neurosciences|July 1, 2008
Predictors of antidepressant response to fluvoxamine obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale for major depressive disorders in Japanese patientsHisashi Higuchi, Kazuhiro Sato, Keizo Yoshida, et al.Clinical Neuropharmacology|March 7, 2006
Response rate obtained using milnacipran depending on the severity of depression in the treatment of major depressive patientsYuka Sugawara, Hisashi Higuchi, Keizo Yoshida, et al.Biological & Pharmaceutical Bulletin|October 6, 2007
No association of the G1287A polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a Japanese populationKazuyuki Inoue, Kunihiko Itoh, Keizo Yoshida, et al.Journal of Psychopharmacology (Oxford, England)|November 10, 2006
The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamineKeizo Yoshida, Hisashi Higuchi, Mitsuhiro Kamata, et al.Psychiatry and Clinical Neurosciences|July 6, 2007
Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patientsShingo Naito, Kazuhiro Sato, Keizo Yoshida, et al.Human Psychopharmacology|November 21, 2007
Influence of the tyrosine hydroxylase val81met polymorphism and catechol-O-methyltransferase val158met polymorphism on the antidepressant effect of milnacipranKeizo Yoshida, Hisashi Higuchi, Hitoshi Takahashi, et al.Human Psychopharmacology|May 27, 2003
Milnacipran plasma levels and antidepressant response in Japanese major depressive patientsHisashi Higuchi, Keizo Yoshida, Hitoshi Takahashi, et al.Pageof 7